NCT02019082

Brief Summary

This study aimed to investigate the effect of low intensity cathodal direct current on the release of plasma vascular endothelial growth factor (VEGF) and nitric oxide (NO) in diabetic foot ulceration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

October 9, 2013

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 24, 2013

Completed
Last Updated

December 24, 2013

Status Verified

December 1, 2013

Enrollment Period

9 months

First QC Date

October 9, 2013

Last Update Submit

December 23, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • The plasma level of VEGF(pg/ml) and NO (microM)

    prior to the 1st electrical stimulation session(day 1) and 1 hour later, and prior to the 12th electrical stimulation session(day 26) and 1 hour later

Secondary Outcomes (4)

  • skin temperature (degree of centigrade)

    prior the 1st electrical stimulation session (day 1) and 1 hour later

  • skin temperature (degree of centigrade)

    prior the 6th electrical stimulation session (day 12) and 1 hour later

  • skin temperature (degree of centigrade)

    prior the 12th electrical stimulation session (day 26) and 1 hour later

  • Wound surface area(cm2)

    on day 1, 12, and 26

Study Arms (2)

electrical stimulation

ACTIVE COMPARATOR

electrical stimulation group, group who received direct current ES at sensory threshold intensity for 1 h/day, 3 days/week, for 4 weeks (12 sessions)

Device: Electrical Stimulation (BTL-5000 series, United Kingdom)

placebo

PLACEBO COMPARATOR

In the placebo group, the treatment procedure was the same as that the ES group, but the current intensity was zero.

Device: placebo

Interventions

Direct current ES

electrical stimulation
placeboDEVICE

the intervention procedure was the same as that the ES group, but the current intensity was zero

placebo

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Wagner classification DFU 2;
  • age 40-60 years;
  • mild to moderate diabetic neuropathy;
  • ABI\>0.7
  • wound surface area\>1.5cm2

You may not qualify if:

  • fracture in a lower limb,
  • a severe infection,
  • a malignancy,
  • kidney failure,
  • skin diseases,
  • osteomyelitis,
  • pregnancy,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physical Therapy Department, Faculty of Medical Sciences

Tehran, Iran

Location

MeSH Terms

Conditions

Diabetic Foot

Interventions

Electric Stimulation

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Intervention Hierarchy (Ancestors)

Physical StimulationInvestigative Techniques

Study Officials

  • giti torkaman, PhD

    professor of physical therapy, physical therapy department, faculty of medical sciences, tarbiat modares univercity

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

October 9, 2013

First Posted

December 24, 2013

Study Start

March 1, 2011

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

December 24, 2013

Record last verified: 2013-12

Locations